スマートピル技術市場：アプリケーション別（カプセル内視鏡、ドラッグデリバリー、患者モニタリング）、対象部位別（食道、胃、小腸、大腸）、適応疾患別（バレット食道、小腸疾患、結腸癌、その他）、エンドユーザー別（病院とクリニック、診断センター、リサーチセンター）。世界の機会分析および産業予測、2020-2030年

Smart Pills Technology Market By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), By Disease Indication (Barrett'S Esophagus, Small Bowel Diseases, Colon Cancer, Others), By End User (Hospitals and Clinics, Diagnostic Centres, Research Centres): Global Opportunity Analysis and Industry Forecast, 2020-2030

スマートピルは、センサー、カメラ、パッチ、トラッカーなどの要素で構成されるカプセルサイズの摂取可能な医療機器で、より良い診断、患者モニタリング、標的薬物送達に役立つ。主にビタミンカプセルの大きさの... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,398 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	234	英語

サマリー

スマートピルは、センサー、カメラ、パッチ、トラッカーなどの要素で構成されるカプセルサイズの摂取可能な医療機器で、より良い診断、患者モニタリング、標的薬物送達に役立つ。主にビタミンカプセルの大きさの錠剤で、小型のウェアラブルセンサーパッチ、モバイルデバイス上のアプリケーション、プロバイダーポータルなどを備えています。飲み込むと腸で活性化され、センサーから患者の健康状態や薬物治療の効果に関する情報が提供され、より多くの情報に基づいた健康管理の決定と最適な治療が可能になります。さらに、スマートピルは消化器系診断の分野にも革命をもたらしました。これらの錠剤は非侵襲的であるため、ユーザーは胃腸の内視鏡検査や大腸内視鏡検査などの侵襲的な処置に対する強力な代替アプローチとなりえます。
老人人口のかなりの増加、癌、糖尿病などの慢性疾患の増加、肥満、胃食道逆流症（GERD）、胃潰瘍などのライフスタイル関連疾患の有病率の急増は、主にスマートピル市場の成長を推進しています。また、スマートピルの開発に向けたR&D投資の増加も、市場の成長をさらに後押ししています。しかし、これらのデバイスの使用増加に関する政府の厳しい規制や、摂取可能なセンサーに関連する高コストが、市場の成長を抑制する要因になると予想されます。
スマートピル市場は、アプリケーション、ターゲット領域、疾患適応症、エンドユーザー、地域に基づいて区分されます。アプリケーション別では、カプセル内視鏡、ドラッグデリバリー、患者モニタリングに市場が分けられます。対象部位別では、食道、胃、小腸、大腸に区分されます。適応疾患別では、バレット食道疾患、小腸疾患（クローン病、小腸腫瘍、セリアック病などに二分）、結腸疾患、その他に区分されます。エンドユーザー別では、スマートピル市場は病院・クリニック、診断センター、研究センターに分けられます。
地域別では、北米、欧州、アジア太平洋、LAMEAに分かれて分析されています。製品開発と研究協力は、市場プレーヤーが採用する主要な戦略です。本レポートでは、世界のスマートピル市場で事業を展開する主要企業の包括的な分析を行っています。
世界のスマートピル市場で活動する主要企業は、CapsoVision, Inc.、Check-Cap Ltd.、HQ.Inc、IntroMedic Co., Ltd、JINSHAN Science & Technology、Koninklijke Philips N.V., Medtronic plc, OLYMPUS Corporation、Proteus Digital Health、RF Co.

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SMART PILLS TECHNOLOGY MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Capsule Endoscopy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Drug Delivery
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Patient Monitoring
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA
5.1 Overview
5.1.1 Market size and forecast
5.2 Esophagus
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Stomach
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Small Intestine
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Large Intestine
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Barrett'S Esophagus
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Small Bowel Diseases
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Colon Cancer
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: SMART PILLS TECHNOLOGY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals and Clinics
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Diagnostic Centres
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Research Centres
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: SMART PILLS TECHNOLOGY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Application
8.2.3 North America Market size and forecast, by Target Area
8.2.4 North America Market size and forecast, by Disease Indication
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Application
8.2.6.1.2 Market size and forecast, by Target Area
8.2.6.1.3 Market size and forecast, by Disease Indication
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Application
8.2.6.2.2 Market size and forecast, by Target Area
8.2.6.2.3 Market size and forecast, by Disease Indication
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Application
8.2.6.3.2 Market size and forecast, by Target Area
8.2.6.3.3 Market size and forecast, by Disease Indication
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Application
8.3.3 Europe Market size and forecast, by Target Area
8.3.4 Europe Market size and forecast, by Disease Indication
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Application
8.3.6.1.2 Market size and forecast, by Target Area
8.3.6.1.3 Market size and forecast, by Disease Indication
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Application
8.3.6.2.2 Market size and forecast, by Target Area
8.3.6.2.3 Market size and forecast, by Disease Indication
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Application
8.3.6.3.2 Market size and forecast, by Target Area
8.3.6.3.3 Market size and forecast, by Disease Indication
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Application
8.3.6.4.2 Market size and forecast, by Target Area
8.3.6.4.3 Market size and forecast, by Disease Indication
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Application
8.3.6.5.2 Market size and forecast, by Target Area
8.3.6.5.3 Market size and forecast, by Disease Indication
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Application
8.3.6.6.2 Market size and forecast, by Target Area
8.3.6.6.3 Market size and forecast, by Disease Indication
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Application
8.4.3 Asia-Pacific Market size and forecast, by Target Area
8.4.4 Asia-Pacific Market size and forecast, by Disease Indication
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Application
8.4.6.1.2 Market size and forecast, by Target Area
8.4.6.1.3 Market size and forecast, by Disease Indication
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Application
8.4.6.2.2 Market size and forecast, by Target Area
8.4.6.2.3 Market size and forecast, by Disease Indication
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Application
8.4.6.3.2 Market size and forecast, by Target Area
8.4.6.3.3 Market size and forecast, by Disease Indication
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Application
8.4.6.4.2 Market size and forecast, by Target Area
8.4.6.4.3 Market size and forecast, by Disease Indication
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Application
8.4.6.5.2 Market size and forecast, by Target Area
8.4.6.5.3 Market size and forecast, by Disease Indication
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest Of Asia Pacific
8.4.6.6.1 Market size and forecast, by Application
8.4.6.6.2 Market size and forecast, by Target Area
8.4.6.6.3 Market size and forecast, by Disease Indication
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Application
8.5.3 LAMEA Market size and forecast, by Target Area
8.5.4 LAMEA Market size and forecast, by Disease Indication
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Application
8.5.6.1.2 Market size and forecast, by Target Area
8.5.6.1.3 Market size and forecast, by Disease Indication
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 South Africa,
8.5.6.2.1 Market size and forecast, by Application
8.5.6.2.2 Market size and forecast, by Target Area
8.5.6.2.3 Market size and forecast, by Disease Indication
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 Saudi Arabia
8.5.6.3.1 Market size and forecast, by Application
8.5.6.3.2 Market size and forecast, by Target Area
8.5.6.3.3 Market size and forecast, by Disease Indication
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Application
8.5.6.4.2 Market size and forecast, by Target Area
8.5.6.4.3 Market size and forecast, by Disease Indication
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 RF Co., Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 JINSHAN Science and Technology
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Proteus Digital Health
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HQ, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 CapsoVision, Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Medtronic Plc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Olympus Corporations
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 IntroMedic Co., Ltd
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Check Cap
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Koninklijke Philips N.V
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 2. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR CAPSULE ENDOSCOPY, BY REGION , 2020-2030,($MILLION)
TABLE 3. SMART PILLS TECHNOLOGY MARKET CAPSULE ENDOSCOPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DRUG DELIVERY, BY REGION , 2020-2030,($MILLION)
TABLE 5. SMART PILLS TECHNOLOGY MARKET DRUG DELIVERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR PATIENT MONITORING, BY REGION , 2020-2030,($MILLION)
TABLE 7. SMART PILLS TECHNOLOGY MARKET PATIENT MONITORING BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 9. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
TABLE 10. SMART PILLS TECHNOLOGY MARKET ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR STOMACH, BY REGION , 2020-2030,($MILLION)
TABLE 12. SMART PILLS TECHNOLOGY MARKET STOMACH BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL INTESTINE, BY REGION , 2020-2030,($MILLION)
TABLE 14. SMART PILLS TECHNOLOGY MARKET SMALL INTESTINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR LARGE INTESTINE, BY REGION , 2020-2030,($MILLION)
TABLE 16. SMART PILLS TECHNOLOGY MARKET LARGE INTESTINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 18. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR BARRETT'S ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
TABLE 19. SMART PILLS TECHNOLOGY MARKET BARRETT'S ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL BOWEL DISEASES, BY REGION , 2020-2030,($MILLION)
TABLE 21. SMART PILLS TECHNOLOGY MARKET SMALL BOWEL DISEASES BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR COLON CANCER, BY REGION , 2020-2030,($MILLION)
TABLE 23. SMART PILLS TECHNOLOGY MARKET COLON CANCER BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 25. SMART PILLS TECHNOLOGY MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 26. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 27. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 28. SMART PILLS TECHNOLOGY MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DIAGNOSTIC CENTRES, BY REGION , 2020-2030,($MILLION)
TABLE 30. SMART PILLS TECHNOLOGY MARKET DIAGNOSTIC CENTRES BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR RESEARCH CENTRES, BY REGION , 2020-2030,($MILLION)
TABLE 32. SMART PILLS TECHNOLOGY MARKET RESEARCH CENTRES BY COUNTRY, 2020-2030,($MILLION)
TABLE 33. SMART PILLS TECHNOLOGY MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 34. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 35. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 36. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 37. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 38. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 39. U.S. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 40. U.S. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 41. U.S. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 42. U.S. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. CANADA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 44. CANADA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 45. CANADA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 46. CANADA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. MEXICO SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 48. MEXICO SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 49. MEXICO SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 50. MEXICO SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. EUROPE SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 52. EUROPE SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 53. EUROPE SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 54. EUROPE SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 55. EUROPE SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 56. GERMANY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 57. GERMANY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 58. GERMANY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 59. GERMANY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. FRANCE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 61. FRANCE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 62. FRANCE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 63. FRANCE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 64. U.K. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 65. U.K. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 66. U.K. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 67. U.K. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 68. ITALY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. ITALY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 70. ITALY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 71. ITALY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 72. SPAIN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 73. SPAIN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 74. SPAIN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 75. SPAIN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 77. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 78. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 79. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 81. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 82. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 83. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 84. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 85. JAPAN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 86. JAPAN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 87. JAPAN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 88. JAPAN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 89. CHINA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 90. CHINA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 91. CHINA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 92. CHINA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 93. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 94. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 95. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 96. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 97. INDIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 98. INDIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 99. INDIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 100. INDIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 101. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 102. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 103. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 104. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 105. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 106. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 107. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 108. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 109. LAMEA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 110. LAMEA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 111. LAMEA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 112. LAMEA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 113. LAMEA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 114. BRAZIL SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 115. BRAZIL SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 116. BRAZIL SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 117. BRAZIL SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 118. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 119. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 120. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 121. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 122. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 123. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 124. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 125. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 126. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 127. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 128. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 129. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 130.RF CO., LTD: COMPANY SNAPSHOT
TABLE 131.RF CO., LTD: OPERATING SEGMENTS
TABLE 132.RF CO., LTD: PRODUCT PORTFOLIO
TABLE 133.RF CO., LTD: NET SALES,
TABLE 134.RF CO., LTD: KEY STRATERGIES
TABLE 135.JINSHAN SCIENCE AND TECHNOLOGY: COMPANY SNAPSHOT
TABLE 136.JINSHAN SCIENCE AND TECHNOLOGY: OPERATING SEGMENTS
TABLE 137.JINSHAN SCIENCE AND TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 138.JINSHAN SCIENCE AND TECHNOLOGY: NET SALES,
TABLE 139.JINSHAN SCIENCE AND TECHNOLOGY: KEY STRATERGIES
TABLE 140.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
TABLE 141.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
TABLE 142.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
TABLE 143.PROTEUS DIGITAL HEALTH: NET SALES,
TABLE 144.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
TABLE 145.HQ, INC.: COMPANY SNAPSHOT
TABLE 146.HQ, INC.: OPERATING SEGMENTS
TABLE 147.HQ, INC.: PRODUCT PORTFOLIO
TABLE 148.HQ, INC.: NET SALES,
TABLE 149.HQ, INC.: KEY STRATERGIES
TABLE 150.CAPSOVISION, INC.: COMPANY SNAPSHOT
TABLE 151.CAPSOVISION, INC.: OPERATING SEGMENTS
TABLE 152.CAPSOVISION, INC.: PRODUCT PORTFOLIO
TABLE 153.CAPSOVISION, INC.: NET SALES,
TABLE 154.CAPSOVISION, INC.: KEY STRATERGIES
TABLE 155.MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 156.MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 157.MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 158.MEDTRONIC PLC.: NET SALES,
TABLE 159.MEDTRONIC PLC.: KEY STRATERGIES
TABLE 160.OLYMPUS CORPORATIONS: COMPANY SNAPSHOT
TABLE 161.OLYMPUS CORPORATIONS: OPERATING SEGMENTS
TABLE 162.OLYMPUS CORPORATIONS: PRODUCT PORTFOLIO
TABLE 163.OLYMPUS CORPORATIONS: NET SALES,
TABLE 164.OLYMPUS CORPORATIONS: KEY STRATERGIES
TABLE 165.INTROMEDIC CO., LTD: COMPANY SNAPSHOT
TABLE 166.INTROMEDIC CO., LTD: OPERATING SEGMENTS
TABLE 167.INTROMEDIC CO., LTD: PRODUCT PORTFOLIO
TABLE 168.INTROMEDIC CO., LTD: NET SALES,
TABLE 169.INTROMEDIC CO., LTD: KEY STRATERGIES
TABLE 170.CHECK CAP: COMPANY SNAPSHOT
TABLE 171.CHECK CAP: OPERATING SEGMENTS
TABLE 172.CHECK CAP: PRODUCT PORTFOLIO
TABLE 173.CHECK CAP: NET SALES,
TABLE 174.CHECK CAP: KEY STRATERGIES
TABLE 175.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
TABLE 176.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
TABLE 177.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
TABLE 178.KONINKLIJKE PHILIPS N.V: NET SALES,
TABLE 179.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.SMART PILLS TECHNOLOGY MARKET SEGMENTATION
FIGURE 2.SMART PILLS TECHNOLOGY MARKET,2020-2030
FIGURE 3.SMART PILLS TECHNOLOGY MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.SMART PILLS TECHNOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.SMART PILLS TECHNOLOGY MARKET,BY APPLICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CAPSULE ENDOSCOPY SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF PATIENT MONITORING SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 15.SMART PILLS TECHNOLOGY MARKET,BY TARGET AREA,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ESOPHAGUS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF STOMACH SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SMALL INTESTINE SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF LARGE INTESTINE SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 20.SMART PILLS TECHNOLOGY MARKET,BY DISEASE INDICATION,2020(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF BARRETT'S ESOPHAGUS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SMALL BOWEL DISEASES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF COLON CANCER SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 25.SMART PILLS TECHNOLOGY MARKET,BY END USER,2020(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTRES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF RESEARCH CENTRES SMART PILLS TECHNOLOGY MARKET,2020-2030(%)
FIGURE 29.SMART PILLS TECHNOLOGY MARKET BY REGION,2020
FIGURE 30.U.S. SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 31.CANADA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 32.MEXICO SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 33.GERMANY SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 34.FRANCE SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 35.U.K. SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 36.ITALY SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 37.SPAIN SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 38.REST OF EUROPE SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 39.JAPAN SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 40.CHINA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 41.AUSTRALIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 42.INDIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 43.SOUTH KOREA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 44.REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 45.BRAZIL SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 46.SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 47.SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 48.REST OF LAMEA SMART PILLS TECHNOLOGY MARKET,2020-2030($MILLION)
FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 53.COMPETITIVE DASHBOARD
FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 55.RF CO., LTD.: NET SALES ,($MILLION)
FIGURE 56.JINSHAN SCIENCE AND TECHNOLOGY.: NET SALES ,($MILLION)
FIGURE 57.PROTEUS DIGITAL HEALTH.: NET SALES ,($MILLION)
FIGURE 58.HQ, INC..: NET SALES ,($MILLION)
FIGURE 59.CAPSOVISION, INC..: NET SALES ,($MILLION)
FIGURE 60.MEDTRONIC PLC..: NET SALES ,($MILLION)
FIGURE 61.OLYMPUS CORPORATIONS.: NET SALES ,($MILLION)
FIGURE 62.INTROMEDIC CO., LTD.: NET SALES ,($MILLION)
FIGURE 63.CHECK CAP.: NET SALES ,($MILLION)
FIGURE 64.KONINKLIJKE PHILIPS N.V.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery. They are majorly available in the form of vitamin capsule-sized pills and possess a small wearable sensor patch, an application on a mobile device, and a provider portal. Once swallowed, it gets activated in the gut; the sensors provide information about the patient’s health parameters and the effectiveness of medication treatment leading to more informed healthcare decisions and optimized therapies. Moreover, smart pills have revolutionized the field of gastrointestinal diagnosis. These pills are non-invasive, and hence the user can be a potent alternative approach against invasive procedures such as gastrointestinal endoscopy/colonoscopy.
A considerable increase in the geriatric population, rise in chronic disorders such as cancer, diabetes, and others, and surge in prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others majorly drive the growth of the smart pills market. In addition, increased R&Dinvestments in developing smart pills further boost the market growth. However, stringent government regulations regarding the increased use of these devices and the high cost associated with the ingestible sensors are the factors anticipated to restrain the growth of the market.
The smart pills market is segmented based on application, target area, disease indication, end-users, and region. On the basis of application, the market is divided into capsule endoscopy, drug delivery, and patient monitoring. By target areas, the market is divided into the esophagus, stomach, small intestine, and large intestine. By disease indication, the market is segmented into Barrett's esophagus disease, small bowel disease (bifurcated into Crohn's disease, small bowel tumor, celiac disease, and others), Colon Disease, and Others. By end-user, the smart pills market is divided into hospitals & clinics, diagnostic centers, and research centers.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global smart pills market.
The key players operating in the global smart pills market include CapsoVision, Inc., Check-Cap Ltd., HQ.Inc., IntroMedic Co., Ltd, JINSHAN Science & Technology, Koninklijke Philips N.V., Medtronic plc, OLYMPUS Corporation, Proteus Digital Health, RF Co., Ltd.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

Allied Market Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?